Acelrx Pharmaceuticals (ACRX) USPTO patents

Utility

Systems, devices and methods for dispensing oral transmucosal dosage forms

13 Jul 21

An apparatus includes a housing and a pushrod.

Edmond Chiu, Casidy Domingo

Filed: 22 Dec 15

Utility

Storage and Dispensing Devices for Administration of Oral Transmucosal Dosage Forms

20 May 21

Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided.

Andrew POUTIATINE, Bruce EDWARDS, Charles RAMPERSAUD, Pamela PALMER, Bradley BLACKWOOD, Benjamin K. YAFFE

Filed: 15 Jan 21

Utility

Storage and dispensing devices for administration of oral transmucosal dosage forms

19 Jan 21

Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided.

Andrew Poutiatine, Bruce Edwards, Charles Rampersaud, Pamela Palmer, Bradley Blackwood, Benjamin K. Yaffe

Filed: 26 Sep 18

Utility

Apparatus for administering small volume oral transmucosal dosage forms

13 Jul 20

Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed.

Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau

Filed: 7 May 17

Utility

Small-volume Oral Transmucosal Dosage Forms

22 Jan 20

Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided.

Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, Andrew I. POUTIATINE

Filed: 8 Jan 19

Utility

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain

16 Dec 19

Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.

Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine

Filed: 4 Oct 18